Praxis precision medicines to host movement disorder day on december 17, 2021

Boston, dec. 10, 2021 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal imbalance, today announced that the company will host a movement disorder day from 9:00 a.m. to 12:00 p.m. et on friday, december 17, 2021 virtually and in new york city.
PRAX Ratings Summary
PRAX Quant Ranking